Shuzo Moritani
- Oncology top 10%
- Molecular Biology
- Pediatrics, Perinatology and Child Health top 5%
- Pharmacology
- Pharmacology top 10%
- Co-authors
- Tetsuya TerasakiKoiçhi YokogawaMasaaki NomuraIkumi TamaiAkira TsujiTakashi TsuruoJunkoh YamashitaYasushi Takabatake
- Topics
- Drug Transport and Resistance Mechanisms (7 papers)Nanoparticle-Based Drug Delivery (3 papers)Metabolism, Diabetes, and Cancer (3 papers)
- Journals
- Journal of Pharmacology and Experimental TherapeuticsJournal of Bone and Mineral ResearchBiochemical Pharmacology
- Partner nations
- JapanUnited States
In The Last Decade
Shuzo Moritani
19 papers receiving 761 citations
Peers
Comparison fields: 5 of 78
- Oncology 389
- Molecular Biology 274
- Pediatrics, Perinatology and Child Health 239
- Pharmacology 77
- Pharmacology 71
Countries citing papers authored by Shuzo Moritani
This map shows the geographic impact of Shuzo Moritani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuzo Moritani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuzo Moritani more than expected).
Fields of papers citing papers by Shuzo Moritani
This network shows the impact of papers produced by Shuzo Moritani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuzo Moritani. The network helps show where Shuzo Moritani may publish in the future.
Co-authorship network of co-authors of Shuzo Moritani
This figure shows the co-authorship network connecting the top 25 collaborators of Shuzo Moritani. A scholar is included among the top collaborators of Shuzo Moritani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuzo Moritani. Shuzo Moritani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 101 | |
| 2 | 45 | |
| 3 | Inhibition of tetrandrine on epidermal growth factor-induced cell transformation and its signal transduction. | 8 |
| 4 | Involvement of ABC transporters in chemosensitivity of human renal cell carcinoma, and regulation of MRP2 expression by conjugated bilirubin. | 13 |
| 5 | 23 | |
| 6 | 9 | |
| 7 | 32 | |
| 8 | Conjugated bilirubin induces multidrug resistance-associated protein 2 mRNA expression and in vivo cisplatin resistance in rat hepatoma AH66 cells. | 6 |
| 9 | 15 | |
| 10 | 18 | |
| 11 | Involvement of multidrug resistance-associated protein 2 in in vivo cisplatin resistance of rat hepatoma AH66 cells. | 15 |
| 12 | 101 | |
| 13 | 3 | |
| 14 | 43 | |
| 15 | 2 | |
| 16 | 243 | |
| 17 | 32 | |
| 18 | 71 | |
| 19 | 3 |
About Shuzo Moritani
Shuzo Moritani is a scholar working on Biochemistry, Oncology and Geriatrics and Gerontology, having authored 19 papers that have together received 783 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (7 papers), Nanoparticle-Based Drug Delivery (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). The work is most often cited by research in Oncology (389 citations), Pediatrics, Perinatology and Child Health (239 citations) and Transplantation (30 citations). Shuzo Moritani has collaborated with scholars based in Japan and United States. Frequent co-authors include Tetsuya Terasaki, Koiçhi Yokogawa, Masaaki Nomura, Ikumi Tamai, Akira Tsuji, Takashi Tsuruo, Junkoh Yamashita, Yasushi Takabatake, Tetsumori Yamashima and Yoshiyuki Tenda. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Bone and Mineral Research and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.